Patient-reported outcomes in patients with relapsing forms of MS switching to teriflunomide from other disease-modifying therapies: Results from the global Phase 4 Teri-PRO study in routine clinical practice
Coyle, Patricia K., Khatri, Bhupendra, Edwards, Keith R., Meca-Lallana, José E., Cavalier, Steve, Rufi, Pascal, Benamor, Myriam, Thangavelu, Karthinathan, Robinson, Miqun, Gold, RalfVolume:
26
Language:
english
Journal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2018.09.017
Date:
November, 2018
File:
PDF, 1.14 MB
english, 2018